News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
815
Sources here
19
Companies here
18
Search results Stored financial headlines

Active search

815 matching headlines

Ticker or company: ABSMain company stories
Clear

Can Astera Labs (ALAB) Justify Its Valuation As Strong Results And Guidance Land?

Astera Labs (ALAB) has released strong earnings and guidance for Q3 2026, leading investors to re-evaluate its valuation. While the company's shares have shown significant momentum recently, a "most followed narrative" suggests the stock is 17.9% undervalued, setting a fair value of $391.77 based …

ALAB main company
Sharemaestro market context Trend signal active 52 weeks +79.6% · Next-week setup positive 59.8% ALAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Proto Labs, Inc. $PRLB Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly reduced its holdings in Proto Labs (NYSE: PRLB) by 73.8% in the second quarter, selling 34,538 shares and retaining 12,238 shares valued at approximately $998,000. Despite this, institutional investors collectively own a substantial 84.54% of the company. Proto Labs …

PRLB main company
Sharemaestro market context Trend signal active 52 weeks +81.2% PRLB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

354,395 Shares in BioAge Labs, Inc. $BIOA Bought by Walleye Capital LLC

Walleye Capital LLC recently acquired 354,395 shares of BioAge Labs, Inc. (NASDAQ:BIOA) for approximately $8.7 million, representing 0.8% of the company. Other institutional investors also increased their stakes in the clinical-stage biotech firm. Analysts have a "Moderate Buy" consensus rating with an average price …

BIOA main company
Sharemaestro market context Price below Trend Line 52 weeks +129.9% · Next-week setup positive 65.7% BIOA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Absci Corporation (NASDAQ:ABSI) Receives Consensus Rating of "Moderate Buy" from Analysts

Absci Corporation (NASDAQ:ABSI) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $13.43. Despite missing quarterly earnings and revenue estimates, institutional investors hold over 52% of the stock. The company leverages machine learning and synthetic biology in …

ABSI main company
Sharemaestro market context Trend signal active 52 weeks +249.0% ABSI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Shattuck Labs (NASDAQ:STTK) Cut to Hold at Wall Street Zen

Wall Street Zen downgraded Shattuck Labs (NASDAQ:STTK) from a "Buy" to a "Hold" rating, though the broader analyst consensus remains a "Moderate Buy" with an average price target of $12.12. The company's shares opened at $7.42, and it reported quarterly EPS of -$0.12, matching …

STTK main company
Sharemaestro market context Trend signal active 52 weeks +672.9% STTK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Will Absci (NASDAQ:ABSI) Spend Its Cash Wisely?

This article analyzes Absci's financial health, specifically its cash burn rate and cash reserves, to assess its ability to fund operations and future growth. It examines the company's current cash runway, which is estimated to be over two years based on recent expenditures. The …

ABSI main company
Sharemaestro market context Trend signal active 52 weeks +249.0% ABSI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Blend Labs (BLND): Lightspeed funds report 0% ownership in amended 13G

Lightspeed venture funds have filed an amended Schedule 13G for Blend Labs (BLND), indicating they no longer beneficially own a significant stake in the company. As of June 30, 2026, various Lightspeed entities reported 0 shares of Blend Labs Class A common stock, representing …

BLND main company
Sharemaestro market context Price below Trend Line 52 weeks -59.5% BLND stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cormorant Asset Management (BIOA) discloses 5.38% BioAge Labs ownership stake

Cormorant Asset Management, LP and Bihua Chen have disclosed a 5.38% beneficial ownership stake in BioAge Labs, Inc. (BIOA), as reported in an amended Schedule 13G filing. This ownership amounts to 2,390,605 shares of common stock, with both shared voting and dispositive power. The …

BIOA main company
Sharemaestro market context Price below Trend Line 52 weeks +129.9% · Next-week setup positive 65.7% BIOA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nano Labs Launches NBNB Program to Build Real-World Asset Infrastructure on BNB Chain

Nasdaq-listed Nano Labs has initiated the "Next Big BNB Program" (NBNB) on BNB Chain to develop a compliance-first infrastructure for real-world asset tokenization. This Hong Kong-based Web3 infrastructure provider aims to bridge traditional assets like equities, bonds, and real estate with blockchain technology through …

NA main company
Sharemaestro market context Price below Trend Line 52 weeks -62.6% · Next-week setup negative 43.0% NA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GeoVax Labs (GOVX): Armistice Capital and Steven Boyd disclose 4.99% stake

Armistice Capital, LLC and Steven Boyd have disclosed a 4.99% beneficial ownership stake in GeoVax Labs, Inc. (GOVX), as detailed in a recent SCHEDULE 13G/A SEC filing. This represents 387,038 shares of common stock with shared voting and dispositive power, as of June 30, …

GOVX main company
Sharemaestro market context Price below Trend Line 52 weeks -96.3% · Next-week setup negative 35.9% GOVX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

T. Rowe Price Investment Management (STTK) reports 15.3% stake in Shattuck Labs

T. Rowe Price Investment Management, Inc. has reported a 15.3% beneficial ownership stake in Shattuck Labs Inc. (STTK), totaling 13,432,540 shares. This ownership is primarily for its advisory clients, with T. Rowe Price Small-Cap Value Fund holding a significant portion (5.6%). The filing clarifies …

STTK main company
Sharemaestro market context Trend signal active 52 weeks +672.9% STTK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Does Astera Labs, Inc. (ALAB) Have the Potential to Rally 30.45% as Wall Street Analysts Expect?

Shares of Astera Labs, Inc. (ALAB) have gained 1% over the past four weeks to close the last trading session at $322.78, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any …

ALAB main company ALAB main company
Sharemaestro market context Trend signal active 52 weeks +56.7% ALAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Buy Astera Labs, Inc. (XALAB) with credit card | How to Buy Astera Labs, Inc.

This article from OKX Europe provides a comprehensive guide on how to buy Astera Labs, Inc. (XALAB) using various payment methods such as credit/debit cards, PayPal, Apple Pay, and bank transfers. It emphasizes OKX's security features, high liquidity, transparency, and user-friendliness, while also advising …

ALAB main company
Sharemaestro market context Trend signal active 52 weeks +79.6% · Next-week setup positive 59.8% ALAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Absci (ABSI) Is Up 14.0% After Positive Early ABS-201 Hair Loss Data And Endometriosis Plans

Absci Corporation's stock (ABSI) rose 14.0% after reporting positive interim Phase 1 results for ABS-201, a drug targeting pattern hair loss, showing favorable safety and tolerability. The company also announced plans to advance ABS-201 to Phase 2 testing for endometriosis in late 2026. This …

ABSI main company
Sharemaestro market context Trend signal active 52 weeks +249.0% ABSI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

The Bull Case For Establishment Labs (ESTA) Could Change Following Raised 2026 Revenue Guidance And Narrowing Losses

Establishment Labs Holdings (ESTA) reported strong Q2 2026 results with increased sales to US$67.54 million and a narrowed net loss of US$11.75 million, leading to raised full-year 2026 revenue guidance to US$269-US$271 million. This positive update suggests growing operational momentum for its Motiva implants. …

ESTA main company
Sharemaestro market context Trend signal active 52 weeks +82.1% ESTA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GeoVax Labs (GOVX) holders report 1.59% stake tied to 118,715 warrants

Ayrton Capital LLC, Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B, and Waqas Khatri collectively reported beneficial ownership of 118,715 shares of GeoVax Labs (GOVX) common stock through warrants. This represents a 1.59% stake based on 7,369,243 shares outstanding as of July …

GOVX main company
Sharemaestro market context Price below Trend Line 52 weeks -96.3% · Next-week setup negative 35.9% GOVX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Planet Labs The Cheapest Stock In The Space Economy?

Key Points Planet Labs’ stock has plunged more than 50% from its all-time high. It's cheaper than its peers, but investors shouldn’t ignore the red flags.10 stocks we like better than Planet Labs PBC › Planet Labs(NYSE: PL), a developer of satellite constellations, went …

PL main company
Sharemaestro market context Price below Trend Line 52 weeks +263.1% PL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context